{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:06Z","timestamp":1790716566481,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/leu.2016.9","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T07:40:17Z","timestamp":1454658017000},"page":"1246-1254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K\/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition"],"prefix":"10.1038","volume":"30","author":[{"given":"S","family":"K\u00f6hrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Havranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G P","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"ten Hacken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Vanura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Jumaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-M","family":"Debatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L H","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"BFleu20169_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","volume":"22","author":"KG Roberts","year":"2012","unstructured":"Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 2012; 22: 153\u2013166.","journal-title":"Cancer Cell"},{"key":"BFleu20169_CR2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758\u2013764.","journal-title":"Nature"},{"key":"BFleu20169_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri2491","volume":"9","author":"S Herzog","year":"2009","unstructured":"Herzog S, Reth M, Jumaa H . Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 2009; 9: 195\u2013205.","journal-title":"Nat Rev Immunol"},{"key":"BFleu20169_CR4","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.febslet.2010.04.057","volume":"584","author":"I-L M\u00e5rtensson","year":"2010","unstructured":"M\u00e5rtensson I-L, Almqvist N, Grimsholm O, Bernardi AI . The pre-B cell receptor checkpoint. FEBS Lett 2010; 584: 2572\u20132579.","journal-title":"FEBS Lett"},{"key":"BFleu20169_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/350423a0","volume":"350","author":"D Kitamura","year":"1991","unstructured":"Kitamura D, Roes J, K\u00fchn R, Rajewsky KA . B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin \u03bc chain gene. Nature 1991; 350: 423\u2013426.","journal-title":"Nature"},{"key":"BFleu20169_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/0092-8674(92)90293-L","volume":"69","author":"D Kitamura","year":"1992","unstructured":"Kitamura D, Kudo A, Schaal S, M\u00fcller W, Melchers F, Rajewsky K . A critical role of \u03bb5 protein in B cell development. Cell 1992; 69: 823\u2013831.","journal-title":"Cell"},{"key":"BFleu20169_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1126\/science.1139412","volume":"316","author":"AJ Bankovich","year":"2007","unstructured":"Bankovich AJ, Raunser S, Juo ZS, Walz T, Davis MM, Garcia KC . Structural insight into Pre-B cell receptor function. Science 2007; 316: 291\u2013294.","journal-title":"Science"},{"key":"BFleu20169_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/ni.1903","volume":"11","author":"R \u00dcbelhart","year":"2010","unstructured":"\u00dcbelhart R, Bach MP, Eschbach C, Wossning T, Reth M, Jumaa H . N-linked glycosylation selectively regulates autonomous precursor BCR function. Nat Immunol 2010; 11: 759\u2013765.","journal-title":"Nat Immunol"},{"key":"BFleu20169_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/ni959","volume":"4","author":"K Ohnishi","year":"2003","unstructured":"Ohnishi K, Melchers F . The nonimmunoglobulin portion of \u03bb5 mediates cell-autonomous pre-B cell receptor signaling. Nat Immunol 2003; 4: 849\u2013856.","journal-title":"Nat Immunol"},{"key":"BFleu20169_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.immuni.2008.02.015","volume":"28","author":"T Yasuda","year":"2008","unstructured":"Yasuda T, Sanjo H, Pag\u00e8s G, Kawano Y, Karasuyama H, Pouyss\u00e9gur J et al. Erk kinases link Pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 2008; 28: 499\u2013508.","journal-title":"Immunity"},{"key":"BFleu20169_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/ni.1616","volume":"9","author":"S Herzog","year":"2008","unstructured":"Herzog S, Hug E, Meixlsperger S, Paik J-H, DePinho RA, Reth M et al. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat Immunol 2008; 9: 623\u2013631.","journal-title":"Nat Immunol"},{"key":"BFleu20169_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/leu.2015.113","volume":"29","author":"J Eswaran","year":"2015","unstructured":"Eswaran J, Sinclair P, Heidenreich O, Irving J, Russell LJ, Hall A et al. The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia. Leukemia 2015; 29: 1623\u20131631.","journal-title":"Leukemia"},{"key":"BFleu20169_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nature14231","volume":"521","author":"Z Chen","year":"2015","unstructured":"Chen Z, Shojaee S, Buchner M, Geng H, Lee JW, Klemm L et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature 2015; 521: 357\u2013361.","journal-title":"Nature"},{"key":"BFleu20169_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","volume":"27","author":"H Geng","year":"2015","unstructured":"Geng H, Hurtz C, Lenz KB, Chen Z, Baumjohann D, Thompson S et al. Self-enforcing feedback activation between BCL6 and Pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia. Cancer Cell 2015; 27: 409\u2013425.","journal-title":"Cancer Cell"},{"key":"BFleu20169_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature09883","volume":"473","author":"C Duy","year":"2011","unstructured":"Duy C, Hurtz C, Shojaee S, Cerchietti L, Geng H, Swaminathan S et al. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature 2011; 473: 384\u2013388.","journal-title":"Nature"},{"key":"BFleu20169_CR16","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1084\/jem.20090004","volume":"206","author":"D Trageser","year":"2009","unstructured":"Trageser D, Iacobucci I, Nahar R, Duy C, Levetzow G, von, Klemm L et al. Pre\u2013B cell receptor\u2013mediated cell cycle arrest in Philadelphia chromosome\u2013positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med 2009; 206: 1739\u20131753.","journal-title":"J Exp Med"},{"key":"BFleu20169_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature01608","volume":"423","author":"H Jumaa","year":"2003","unstructured":"Jumaa H, Bossaller L, Portugal K, Storch B, Lotz M, Flemming A et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 2003; 423: 452\u2013456.","journal-title":"Nature"},{"key":"BFleu20169_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.20042101","volume":"201","author":"N Feldhahn","year":"2005","unstructured":"Feldhahn N, Klein F, Mooster JL, Hadweh P, Sprangers M, Wartenberg M et al. Mimicry of a constitutively active pre\u2013B cell receptor in acute lymphoblastic leukemia cells. J Exp Med 2005; 201: 1837\u20131852.","journal-title":"J Exp Med"},{"key":"BFleu20169_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/nm.3247","volume":"19","author":"S Swaminathan","year":"2013","unstructured":"Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H et al. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint. Nat Med 2013; 19: 1014\u20131022.","journal-title":"Nat Med"},{"key":"BFleu20169_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccr.2012.08.027","volume":"22","author":"VT Bicocca","year":"2012","unstructured":"Bicocca VT, Chang BH, Masouleh BK, Muschen M, Loriaux MM, Druker BJ et al. Crosstalk between ROR1 and the Pre-B cellreceptor promotes survival of t(1;19) acute lymphoblastic leukemia. Cancer Cell 2012; 22: 656\u2013667.","journal-title":"Cancer Cell"},{"key":"BFleu20169_CR21","doi-asserted-by":"publisher","first-page":"236ra62","DOI":"10.1126\/scitranslmed.3008661","volume":"6","author":"T Perova","year":"2014","unstructured":"Perova T, Grandal I, LMJ Nutter, Papp E, Matei IR, Beyene J et al. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia. Sci Transl Med 2014; 6: 236ra62.","journal-title":"Sci Transl Med"},{"key":"BFleu20169_CR22","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1182\/blood-2012-11-470633","volume":"121","author":"FM Uckun","year":"2013","unstructured":"Uckun FM, Qazi S, Cely I, Sahin K, Shahidzadeh A, Ozercan I et al. Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia. Blood 2013; 121: 4348\u20134354.","journal-title":"Blood"},{"key":"BFleu20169_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2141.2010.08106.x","volume":"149","author":"FM Uckun","year":"2010","unstructured":"Uckun FM, Ek RO, Jan S-T, Chen C-L, Qazi S . Targeting SYK kinase-dependent anti-apoptotic resistance pathway in B-lineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimic. Br J Haematol 2010; 149: 508\u2013517.","journal-title":"Br J Haematol"},{"key":"BFleu20169_CR24","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1038\/bcj.2014.5","volume":"4","author":"A van der Veer","year":"2014","unstructured":"van der Veer A, van der Velden VHJ, Willemse ME, Hoogeveen PG, Petricoin EF, Beverloo HB et al. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood Cancer J 2014; 4: e181.","journal-title":"Blood Cancer J"},{"key":"BFleu20169_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nri3570","volume":"14","author":"MR Clark","year":"2014","unstructured":"Clark MR, Mandal M, Ochiai K, Singh H . Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol 2014; 14: 69\u201380.","journal-title":"Nat Rev Immunol"},{"key":"BFleu20169_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.smim.2005.11.002","volume":"18","author":"M Espeli","year":"2006","unstructured":"Espeli M, Rossi B, Mancini SJC, Roche P, Gauthier L, Schiff C . Initiation of pre-B cell receptor signaling: common and distinctive features in human and mouse. Semin Immunol 2006; 18: 56\u201366.","journal-title":"Semin Immunol"},{"key":"BFleu20169_CR27","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/leu.2012.24","volume":"26","author":"J Hoellenriegel","year":"2012","unstructured":"Hoellenriegel J, Coffey GP, Sinha U, Pandey A, Sivina M, Ferrajoli A et al. Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration. Leukemia 2012; 26: 1576\u20131583.","journal-title":"Leukemia"},{"key":"BFleu20169_CR28","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"F Ann Ran","year":"2013","unstructured":"Ann Ran F, Hsu Patrick D, Wright Jason, Agarwala Vineeta, Scott David A, Zhang Feng . Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013; 8: 2281\u20132308.","journal-title":"Nat Protoc"},{"key":"BFleu20169_CR29","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1128\/MCB.20.23.8969-8982.2000","volume":"20","author":"N Nakamura","year":"2000","unstructured":"Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR . Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 2000; 20: 8969\u20138982.","journal-title":"Mol Cell Biol"},{"key":"BFleu20169_CR30","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1158\/1055-9965.EPI-10-0565","volume":"19","author":"W Ma","year":"2010","unstructured":"Ma W, Wang M, Wang Z-Q, Sun L, Graber D, Matthews J et al. Effect of long-term storage in TRIzol on microarray-based gene expression profiling. Cancer Epidemiol Biomark Prev 2010; 19: 2445\u20132452.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"BFleu20169_CR31","doi-asserted-by":"publisher","first-page":"11339","DOI":"10.1093\/nar\/gks957","volume":"40","author":"S-T Lee","year":"2012","unstructured":"Lee S-T, Xiao Y, Muench MO, Xiao J, Fomin ME, Wiencke JK et al. A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network. Nucleic Acids Res 2012; 40: 11339\u201311351.","journal-title":"Nucleic Acids Res"},{"key":"BFleu20169_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFleu20169_CR33","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu20169_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267\u2013273.","journal-title":"Nat Genet"},{"key":"BFleu20169_CR35","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.4049\/jimmunol.179.6.3662","volume":"179","author":"ME Hystad","year":"2007","unstructured":"Hystad ME, Myklebust JH, B\u00f8 TH, Sivertsen EA, Rian E, Forfang L et al. Characterization of early stages of human B cell development by gene expression profiling. J Immunol 2007; 179: 3662\u20133671.","journal-title":"J Immunol"},{"key":"BFleu20169_CR36","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/molbev\/msm198","volume":"24","author":"R Hoffmann","year":"2007","unstructured":"Hoffmann R, Lottaz C, K\u00fchne T, Rolink A, Melchers F . Neutrality, compensation, and negative selection during evolution of B-cell development transcriptomes. Mol Biol Evol 2007; 24: 2610\u20132618.","journal-title":"Mol Biol Evol"},{"key":"BFleu20169_CR37","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood.V92.11.4317","volume":"92","author":"K Tsuganezawa","year":"1998","unstructured":"Tsuganezawa K, Kiyokawa N, Matsuo Y, Kitamura F, Toyama-Sorimachi N, Kuida K et al. Flow cytometric diagnosis of the cell lineage and developmental stage of acute lymphoblastic leukemia by novel monoclonal antibodies specific to human Pre\u2013B-cell receptor. Blood 1998; 92: 4317\u20134324.","journal-title":"Blood"},{"key":"BFleu20169_CR38","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1182\/blood-2010-03-274969","volume":"117","author":"MP Reilly","year":"2011","unstructured":"Reilly MP, Sinha U, Andr\u00e9 P, Taylor SM, Pak Y, DeGuzman FR et al. PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model. Blood 2011; 117: 2241\u20132246.","journal-title":"Blood"},{"key":"BFleu20169_CR39","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1182\/blood-2011-02-333773","volume":"118","author":"S Cheng","year":"2011","unstructured":"Cheng S, Coffey G, Zhang XH, Shaknovich R, Song Z, Lu P et al. SYK inhibition and response prediction in diffuse large B-cell lymphoma. Blood 2011; 118: 6342\u20136352.","journal-title":"Blood"},{"key":"BFleu20169_CR40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ccr.2013.05.002","volume":"23","author":"L Chen","year":"2013","unstructured":"Chen L, Monti S, Juszczynski P, Ouyang J, Chapuy B, Neuberg D et al. SYK inhibition modulates distinct PI3K\/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. Cancer Cell 2013; 23: 826\u2013838.","journal-title":"Cancer Cell"},{"key":"BFleu20169_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1124\/jpet.111.188441","volume":"340","author":"G Coffey","year":"2012","unstructured":"Coffey G, DeGuzman F, Inagaki M, Pak Y, Delaney SM, Ives D et al. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis. J Pharmacol Exp Ther 2012; 340: 350\u2013359.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFleu20169_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1074-7613(00)00024-8","volume":"13","author":"B Guo","year":"2000","unstructured":"Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ . Engagement of the human pre-B cell receptor generates a lipid raft\u2013dependent calcium signaling complex. Immunity 2000; 13: 243\u2013253.","journal-title":"Immunity"},{"key":"BFleu20169_CR43","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1158\/0008-5472.CAN-06-0411","volume":"66","author":"X-Y Dong","year":"2006","unstructured":"Dong X-Y, Chen C, Sun X, Guo P, Vessella RL, Wang R-X et al. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res 2006; 66: 6998\u20137006.","journal-title":"Cancer Res"},{"key":"BFleu20169_CR44","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1182\/blood-2011-09-381905","volume":"119","author":"L Xie","year":"2012","unstructured":"Xie L, Ushmorov A, Leith\u00e4user F, Guan H, Steidl C, F\u00e4rbinger J et al. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood 2012; 119: 3503\u20133511.","journal-title":"Blood"},{"key":"BFleu20169_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cell.2011.07.032","volume":"146","author":"SM Sykes","year":"2011","unstructured":"Sykes SM, Lane SW, Bullinger L, Kalaitzidis D, Yusuf R, Saez B et al. AKT\/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 2011; 146: 697\u2013708.","journal-title":"Cell"},{"key":"BFleu20169_CR46","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ni1008-1091","volume":"9","author":"TSP Heng","year":"2008","unstructured":"Heng TSP, Painter MW . Immunological Genome Project Consortium. The immunological genome project: networks of gene expression in immune cells. Nat Immunol 2008; 9: 1091\u20131094.","journal-title":"Nat Immunol"},{"key":"BFleu20169_CR47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2010.10.019","volume":"18","author":"B Gan","year":"2010","unstructured":"Gan B, Lim C, Chu G, Hua S, Ding Z, Collins M et al. FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. Cancer Cell 2010; 18: 472\u2013484.","journal-title":"Cancer Cell"},{"key":"BFleu20169_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503\u2013511.","journal-title":"Nature"},{"key":"BFleu20169_CR49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1124\/jpet.106.109058","volume":"319","author":"S Braselmann","year":"2006","unstructured":"Braselmann S, Taylor V, Zhao H, Wang S, Sylvain C, Baluom M et al. R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation. J Pharmacol Exp Ther 2006; 319: 998\u20131008.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFleu20169_CR50","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G et al. Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 2011; 29: 1046\u20131051.","journal-title":"Nat Biotechnol"},{"key":"BFleu20169_CR51","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang Y-L, Pei D et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 2014; 371: 1005\u20131015.","journal-title":"N Engl J Med"},{"key":"BFleu20169_CR52","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1182\/blood-2012-03-415448","volume":"120","author":"SL Maude","year":"2012","unstructured":"Maude SL, Tasian SK, Vincent T, Hall JW, Sheen C, Roberts KG et al. Targeting JAK1\/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood 2012; 120: 3510\u20133518.","journal-title":"Blood"},{"key":"BFleu20169_CR53","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1084\/jem.20060967","volume":"203","author":"T Wossning","year":"2006","unstructured":"Wossning T, Herzog S, Kohler F, Meixlsperger S, Kulathu Y, Mittler G et al. Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells. J Exp Med 2006; 203: 2829\u20132840.","journal-title":"J Exp Med"},{"key":"BFleu20169_CR54","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","volume":"117","author":"SEM Herman","year":"2011","unstructured":"Herman SEM, Gordon AL, Hertlein E, Ramanunni A, Zhang X, Jaglowski S et al. Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. Blood 2011; 117: 6287\u20136296.","journal-title":"Blood"},{"key":"BFleu20169_CR55","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1182\/blood-2011-10-386417","volume":"119","author":"S Ponader","year":"2012","unstructured":"Ponader S, Chen S-S, Buggy JJ, Balakrishnan K, Gandhi V, Wierda WG et al. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood 2012; 119: 1182\u20131189.","journal-title":"Blood"},{"key":"BFleu20169_CR56","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V87.4.1211.bloodjournal8741211","volume":"87","author":"SP Hunger","year":"1996","unstructured":"Hunger SP . Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 1996; 87: 1211\u20131224.","journal-title":"Blood"},{"key":"BFleu20169_CR57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1083\/jcb.200704173","volume":"179","author":"T Habib","year":"2007","unstructured":"Habib T, Park H, Tsang M, de Albor\u00e1n IM, Nicks A, Wilson L et al. Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J Cell Biol 2007; 179: 717\u2013731.","journal-title":"J Cell Biol"},{"key":"BFleu20169_CR58","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1126\/science.283.5400.390","volume":"283","author":"H Suzuki","year":"1999","unstructured":"Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T et al. Xid-Like immunodeficiency in mice with disruption of the p85\u03b1 subunit of phosphoinositide 3-Kinase. Science 1999; 283: 390\u2013392.","journal-title":"Science"},{"key":"BFleu20169_CR59","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1182\/blood-2007-08-109769","volume":"111","author":"Y Aiba","year":"2008","unstructured":"Aiba Y, Kameyama M, Yamazaki T, Tedder TF, Kurosaki T . Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 2008; 111: 1497\u20131503.","journal-title":"Blood"},{"key":"BFleu20169_CR60","doi-asserted-by":"publisher","first-page":"ra60","DOI":"10.1126\/scisignal.2001104","volume":"3","author":"F Ramadani","year":"2010","unstructured":"Ramadani F, Bolland DJ, Garcon F, Emery JL, Vanhaesebroeck B, Corcoran AE et al. The PI3K Isoforms p110\u03b1 and p110\u03b4 are essential for Pre\u2013B cell receptor signaling and B cell development. Sci Signal 2010; 3: ra60.","journal-title":"Sci Signal"},{"key":"BFleu20169_CR61","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/378298a0","volume":"378","author":"M Turner","year":"1995","unstructured":"Turner M, Joseph Mee P, Costello PS, Williams O, Price AA, Duddy LP et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995; 378: 298\u2013302.","journal-title":"Nature"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu20169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu20169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu20169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:20:07Z","timestamp":1648747207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu20169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFleu20169"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]},"assertion":[{"value":"21 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JAB received research funding from Portola Pharmaceuticals and GPC is employee and shareholder of Portola Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}